Milestone Asset Management LLC Invests $2.25 Million in Bristol Myers Squibb Company $BMY

robot
Abstract generation in progress

Milestone Asset Management LLC has acquired a new position in Bristol Myers Squibb Company, purchasing shares valued at approximately $2.25 million. Several other institutional investors also adjusted their holdings in the biopharmaceutical company during the fourth quarter. The article also covers recent insider transactions, stock performance, dividend announcements, and analyst ratings for Bristol Myers Squibb.

This page may contain third-party content, which is provided for information purposes only (not representations/warranties) and should not be considered as an endorsement of its views by Gate, nor as financial or professional advice. See Disclaimer for details.
  • Reward
  • Comment
  • Repost
  • Share
Comment
Add a comment
Add a comment
No comments
  • Pin